Related Experiment Video
Updated: May 2, 2026

Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
Published on: October 8, 2015
Breaking barriers: noninvasive AI model for BRAFV600E mutation identification
Fan Wu1, Xiangfeng Lin2, Yuying Chen3
1Department of Oncological Surgery, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, 310006, Zhejiang, China.
This study developed a noninvasive AI model using ultrasound images and deep transfer learning to identify BRAFV600E mutations in papillary thyroid cancer. The DTLR model achieved high accuracy, offering a promising alternative to invasive genetic testing.
Area of Science:
- Radiology
- Oncology
- Artificial Intelligence
Background:
- BRAFV600E mutation is common in papillary thyroid carcinoma (PTC).
- Current BRAFV600E mutation detection methods are invasive.
- Noninvasive methods for identifying BRAFV600E mutations are needed.
Purpose of the Study:
- To develop a noninvasive artificial intelligence (AI) model for identifying BRAFV600E mutations in PTC.
- To extract radiomic features and utilize deep transfer learning (DTL) from ultrasound images.
- To combine DTL and radiomics for improved diagnostic capability.
Main Methods:
- Regions of interest (ROIs) were annotated in ultrasound images.
- Radiomic and DTL features were extracted and combined into a DTLR model.
- LASSO regression was used for feature selection, and eight machine learning methods were employed for model construction.
- Performance was evaluated using AUC, accuracy, sensitivity, and specificity. Grad-CAM was used for visualization.
Main Results:
- The DTLR model, particularly with ResNet152, effectively identified BRAFV600E mutations.
- The optimal DTLR model achieved an AUC of 0.833, accuracy of 80.6%, sensitivity of 76.2%, and specificity of 81.7% in the validation set.
- The DTLR model outperformed standalone DTL and radiomics models.
- Grad-CAM visualization confirmed the model's ability to identify relevant ultrasound image features.
Conclusions:
- The ResNet152-based DTLR model shows significant potential for noninvasively identifying BRAFV600E mutations in PTC patients using ultrasound.
- Grad-CAM can aid in visually stratifying BRAF mutations.
- Further multi-center validation with larger datasets is recommended.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024